18:48 IST
BSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Ltd has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(c) of the SEBI Listing Regulations.
Ind-Swift Laboratories Ltd
- Share price
- ₹392.50
- Market cap
- ₹3,413 Cr
- Revenue (annual)
- ₹641.3 Cr
- Net profit (annual)
- ₹41.42 Cr
- P/E (TTM)
- 59.5×Sector 47.4×
- Promoter holding
- 42.93%-0.06% QoQ
- FII holding
- 10.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
18:10 IST
NSE
Capital Structure Change
Ind-Swift Laboratories Capital Structure Change
Promoter entity Essix Biosciences Limited acquired 70,00,000 fully convertible warrants of Ind-Swift Laboratories via a preferential allotment.
18:01 IST
BSE
Capital Structure Change
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 70 lakh fully convertible warrants at Rs. 196 each, totaling Rs. 137.2 Crore. This preferential issue will augment capital upon warrant conversion.
- Value
- ₹137.2 Cr
17:45 IST
NSE
Capital Structure Change
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories Limited allotted 70,00,000 fully convertible warrants to Essix Biosciences Limited on a preferential basis. The company received Rs. 34.30 Crore as upfront payment.
- Value
- ₹34.30 Cr